In C6 glioma cells, inhibition of NLRP3 through beta-hydroxybutyrate (BHB) reduces caspase-1 and suppresses cell migration, likely by reducing ACS oligomerization or preventing K+ efflux [226]. The gene discussed is NLRP3; the disease is central nervous system cancer.